Pharmaceutical Technology
SEPTEMBER 14, 2022
API peptides and proteins-based drugs have gained much attention in the past decade. Discover the top API protein and peptide companies in contract marketing. Technologies in the delivery of peptides and proteins. They are promising therapeutics for the treatment of a variety of metabolic and oncological disorders.
Drug Discovery World
MAY 25, 2023
The platform works with the SYNTAX Hi-Fidelity reagent kits for synthesising longer oligos. Gyros Protein Technologies: Gyrolab Generic Cyno Anti-Drug Antibodies (ADA) Kit Reagents The kit reagents are for the detection of circulating immune complexes of human IgG with cyno anti-human IgG.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
JANUARY 10, 2023
Our catalog of over 6,500+ primary antibodies, 1,200+ secondary antibodies, and 50+ ELISA kits includes reagents for multiplex IF, flow cytometry, and more in fields including immunology, oncology, and neuroscience. This pillar requires that two or more antibodies directed against different epitopes of a protein generate similar results.
Drug Discovery World
SEPTEMBER 29, 2022
During a 2021 webinar on optimising assay development for hit identification, a survey asked over 50 drug discovery scientists, “Which goal is the highest priority when developing a drug discovery assay?”. Minimising reagent consumption and costs. Generating robust, reproducible data generating confidence in results.
Drug Discovery World
APRIL 3, 2023
As a business of scientists, we remain passionate about the exciting developments in the industry, from research to precision therapies, and insatiably curious about the new possibilities that can be achieved by overcoming the limits of standard research tools and methods. To what do you attribute your success?
Drug Discovery World
NOVEMBER 28, 2023
Scientists at the University of Bath have developed a way of joining up the head and tail of a protein, making it more stable and easier to get into cells. Drug treatments often work by binding to proteins involved in disease and blocking their activity, which either reduces symptoms or treats the disease.
Pharmaceutical Technology
APRIL 28, 2023
Its scope includes Syngene providing integrated drug discovery and development solutions in discovery chemistry and biology, peptide chemistry, antibody and protein reagents, pharmacokinetics and drug metabolism, and pharmaceutical development. until 2026. Profile Syngene International Ltd.
Expert insights. Personalized for you.
130 
Let's personalize your content